How recent advances in molecular tests could impact the diagnosis of pneumonia

Expert Review of Molecular Diagnostics

Volumn 16, Issue 5, 2016, Pages 533-540

  Murdoch, David R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

diagnostics; etiology; microbiome; molecular tests; PCR; Pneumonia

Indexed keywords

BACTERIAL PNEUMONIA; BORDETELLA PERTUSSIS; CHLAMYDIA PNEUMONIAE; CHLAMYDIAL PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; LEGIONELLA; LEGIONNAIRE DISEASE; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEIC ACID ANALYSIS; PATHOGENESIS; PERTUSSIS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; RESPIRATORY VIRUS; REVIEW; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; VIRAL RESPIRATORY TRACT INFECTION; BLOOD CULTURE; DEVICES; DIAGNOSTIC KIT; DIAGNOSTIC TEST; GENETICS; LUNG; MICROBIOLOGY; MICROFLORA; NASOPHARYNX; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PRACTICE GUIDELINE; PROCEDURES; UTILIZATION; VIROLOGY;

DIAGNOSTIC KIT;

BLOOD CULTURE; DIAGNOSTIC TESTS, ROUTINE; GUIDELINES AS TOPIC; HUMANS; LUNG; MICROBIOTA; MOLECULAR DIAGNOSTIC TECHNIQUES; NASOPHARYNX; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; REAGENT KITS, DIAGNOSTIC;

EID: 84961215852     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2016.1156536     Document Type: Review

References (97)

1. Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2013;386:743-800.
2. Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381:1405-1416.
3. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371:1619-1628.
4. Murdoch DR, O'Brien KL, Scott JAG, et al. Breathing new life into pneumonia diagnostics. J Clin Microbiol. 2009;47:3405-3408.
5. Murdoch DR, O'Brien KL, Driscoll AJ, et al. Laboratory methods for determining pneumonia etiology in children. Clinl Infect Dis. 2012;54:S146-S52.
6. Hanquet G, Valenciano M, Simondon F, et al. Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine. 2013;31:5634-5642.
7. Ideh RC, Howie SR, Ebruke B, et al. Transthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The Gambia. Int J Tuberc Lung Dis. 2011;15:729-735.
8. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64:iii1-iii55.
9. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-S72.
10. National institute for health and care excellence. Pneumonia in adults: diagnosis and management. Manchester: National Institute for Health and Care Excellence; 2014.
11. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011;53:e25-e76.
12. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66:ii1-ii23.
13. Sloots TP, Nissen MD, Ginn AN, et al. Rapid identification of pathogens using molecular techniques. Pathology. 2015;47:191-198.
14. Faye O, Faye O, Soropogui B, et al. Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill. 2015;20:44.
15. Kumar S, Henrickson KJ. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev. 2012;25:344-361.
16. Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222.
17. Murdoch DR. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis. 2003;36:1162-1170.
18. Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. Apmis. 2004;112:713-727.
19. Somerville LK, Ratnamohan VM, Dwyer DE, et al. Molecular diagnosis of respiratory viruses. Pathology. 2015;47:243-249.
20. Mahony JB. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther. 2010;8:1273-1292.
21. Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377:1264-1275.
22. Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis. 2011;52: S284-S9.
23. Schreckenberger PC, McAdam AJ. Point-counterpoint: large multiplex PCR panels should be first-line tests for detection of respiratory and intestinal pathogens. J Clin Microbiol. 2015;53:3110-3115.
24. Hammitt LL, Kazungu S, Morpeth SC, et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis. 2012;54:S190-S9.
25. Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax. 2015;70:847-853.
26. Phin N, Parry-Ford F, Harrison T, et al. Epidemiology and clinical management of Legionnaires' disease. Lancet Infect Dis. 2014;14:1011-1021.
27. Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28:95-133.
28. Pedro-Botet ML, Sabria M, Sopena N, et al. Environmental legionellosis and oropharyngeal colonization by Legionella in immunosuppressed patients. Infect Control Hosp Epidemiol. 2002;23:279-281.
29. Diederen BM, Kluytmans JA, Vandenbroucke-Grauls CM, et al. Utility of real-time PCR for diagnosis of legionnaires' disease in routine clinical practice. J Clin Microbiol. 2008;46:671-677.
30. Murdoch DR, Chambers ST. Detection of Legionella DNA in peripheral leukocytes, serum, and urine from a patient with pneumonia caused by Legionella dumoffii. Clin Infect Dis. 2000;30:382-383.
31. Murdoch DR, Podmore RG, Anderson TP, et al. Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study. Clin Infect Dis. 2013;57:1275-1281.
32. Murdoch DR, Walford EJ, Jennings LC, et al. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin Infect Dis. 1996;23:475-480.
33. Ramirez JA, Ahkee S, Tolentino A, et al. Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis. 1996;24:7-14.
34. Diederen BMW, Bruin JP, Den Boer JW, et al. Sensitivity of Legionella pneumophila DNA detection in serum samples in relation to disease severity. J Med Microbiol. 2007;56:1255.
35. Maze MJ, Slow S, Cumins A-M, et al. Enhanced detection of Legionnaires' disease by PCR testing of induced sputum and throat swabs. Eur Respir J. 2014;43:644-646.
36. Evans GE, Murdoch DR, Anderson TP, et al. Contamination of Qiagen DNA extraction kits with Legionella DNA. J Clin Microbiol. 2003;41:3452-3453.
37. Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis. 2010;29:1055-1069.
38. Waites KB, Xiao L, Paralanov V, et al. Molecular methods for the detection of Mycoplasma and Ureaplasma infections in humans. J Mol Diagn. 2012;14:437-450.
39. Waller JL, Diaz MH, Petrone BL, et al. Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol. 2014;52:849-853.
40. Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93.
41. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect. 2009;15:29-35.
42. Burillo A, Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am. 2010;24:61-71.
43. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Diseases Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001;33:492-503.
44. Tasaka S, Tokuda H. Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults. Expert Opin Med Diagn. 2013;7:85-97.
45. Takahashi T, Goto M, Endo T, et al. Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection. J Med Microbiol. 2002;51:611-614.
46. Louis M, Guitard J, Jodar M, et al. Impact of HIV infection status on interpretation of quantitative PCR for detection of Pneumocystis jirovecii. J Clin Microbiol. 2015;53:3870-3875.
47. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis. 2015;211:S21-S8.
48. Noor KM, Shephard L, Bastian I. Molecular diagnostics for tuberculosis. Pathology. 2015;47:250-256.
49. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization; 2013.
50. Loeffelholz M. Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests. J Clin Microbiol. 2012;50:2186-2190.
51. Riffelmann M, Wirsing Von König CH, Caro V, et al. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43:4925-4929.
52. Van Der Zee A, Schellekens JFP, Mooi FR. Laboratory diagnosis of pertussis. Clin Microbiol Rev. 2015;28:1005-1026.
53. Beynon KA, Young SA, Laing RTR, et al. Bordetella pertussis in adult pneumonia patients. Emerg Infect Dis. 2005;11:639-641.
54. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paed Respir Rev. 2008;9:201-212.
55. Horby P, Macintyre CR, McIntyre PB, et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol Infect. 2005;133:229-236.
56. Leekha S, Thompson RL, Sampathkumar P. Epidemiology and control of pertussis outbreaks in a tertiary care center and the resource consumption associated with these outbreaks. Infect Control Hosp Epidemiol. 2009;30:467-473.
57. Werno AM, Murdoch DR. Laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis. 2008;46:926-932.
58. Adegbola RA, DeAntonio R, Hill PC, et al. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS ONE. 2014;9:e103293.
59. Murdoch DR, Anderson TP, Beynon KA, et al. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41:63-66.
60. Carvalho M, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lyt A, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45:2460-2466.
61. Azzari C, Moriondo M, Indolfi G, et al. Real-time PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One. 2010;5:e9282.
62. Azzari C, Moriondo M, Indolfi G, et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol. 2008;57:1205-1212.
63. Esposito S, Marchese A, Tozzi AE, et al. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Pediatr Infect Dis J. 2012;31:705-710.
64. Marchese A, Esposito S, Coppo E, et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by realtime polymerase chain reaction using blood samples from Italian children ≤5 years of age with community-acquired pneumonia. Microb Drug Resist. 2011;17:419-424.
65. Azzari C, Cortimiglia M, Moriondo M, et al. Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene. J Med Microbiol. 2011;60:710-714.
66. Avni T, Mansur N, Leibovici L, et al. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol. 2010;48:489-496.
67. The PERCH study group. Detection of Streptococcus pneumoniae by whole blood lytA PCR and association with pediatric pneumonia. Pneumonia. 2014;3:63.
68. Marimon JM, Morales M, Cilla G, et al. Detection of bacteria and viruses in the pleural effusion of children and adults with community-acquired pneumonia. Future Microbiol. 2015;10:909-915.
69. Strachan RE, Cornelius A, Gilbert GL, et al. Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology. 2012;17:114-119.
70. Chiu CY. Viral pathogen discovery. Curr Opin Microbiol. 2013;16:468-478.
71. Lipkin WI. The changing face of pathogen discovery and surveillance. Nat Rev Microbiol. 2013;11:133-141.
72. Thorburn F, Bennett S, Modha S, et al. The use of next generation sequencing in the diagnosis and typing of respiratory infections. J Clin Virol. 2015;69:96-100.
73. Evans JP, Watson MS. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine. JAMA. 2015;313:669-670.
74. Sharfstein J. FDA regulation of laboratory-developed diagnostic tests: protect the public, advance the science. JAMA. 2015;313:667-668.
75. Dickson RP, Huffnagle GB. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015;11:e1004923.
76. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252-262.
77. Brealey JC, Sly PD, Young PR, et al. Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiology Letters. 2015;362:fnv062 .
78. Cillóniz C, Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology. 2016;21:65-75.
79. Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4:59-72.
80. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med. 2014;2:238-246.
81. Rogers GB, Wesselingh S. Precision respiratory medicine and the microbiome. Lancet Respir Med. 2016;4:73-82.
82. Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio. 2015;6:e00037.
83. Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:7.1-7.24.
84. Kwong JC, McCallum N, Sintchenko V, et al.Whole genome sequencing in clinical and public health microbiology. Pathology. 2015;47:199-210.
85. Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016. doi:10.1093/cid/civ1214. [Epub ahead of print].
86. Stralin K, Herrmann B, Abdeldaim G, et al. Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia. J Clin Microbiol. 2014;52:83-89.
87. Albrich WC, Madhi SA, Adrian PV, et al. Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults. J Clin Microbiol. 2014;52:4224-4229.
88. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis. 2012;54:601-609.
89. Albrich WC, Madhi SA, Adrian PV, et al. Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia. BMJ Open. 2014;4:e005953.
90. Werno AM, Anderson TP, Murdoch DR. Association between pneumococcal load and disease severity in adults with pneumonia. J Med Microbiol. 2012;61:1129-1135.
91. Rello J, Lisboa T, Lujan M, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest. 2009;136:832-840.
92. Butler JC, Bosshardt SC, Phelan M, et al. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis. 2003;187:1416-1423.
93. Jokinen J, Scott JA. Estimating the proportion of pneumonia attributable to pneumococcus in Kenyan adults: latent class analysis. Epidemiology. 2010;21:719-725.
94. Bojang AL, Mendy FS, Tientcheu LD, et al. Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia. J Infect. 2016;72(3):332-337.
95. Ling DI, Pai M, Schiller I, et al. A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard. BMC Med Res Methodol. 2014;14:67.
96. Levine OS, O'Brien KL, Deloria-Knoll M, et al. The pneumonia etiology research for child health project: A 21st century childhood pneumonia etiology study. Clin Infect Dis. 2012;54:S93- S101.
97. Wu Z, Deloria-Knoll M, Hammitt LL, et al. The pneumonia etiology research for child health core team. Partially latent class models for case-control studies of childhood pneumonia aetiology. J Roy Stat Soc: Series C (Applied Statistics). 2016;65:97-114.